Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 125.00% vs -9.09% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -40.00% vs -42.86% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -66.67% vs 0.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Oryzon Genomics SA With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 200.00% vs 105.88% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 125.00% vs -9.09% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -40.00% vs -42.86% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs -50.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -66.67% vs 0.00% in Sep 2024






